PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine
is invited to give a keynote presentation at 9TH CLINICAL TRIALS INNOVATION PROGRAMME on April 26-27, 2018.
Event: 9TH CLINICAL TRIALS INNOVATION PROGRAMME
Presentation Date: Thursday, April 26th, 2018
Presentation Time: 12:10 - 12:40 PM
Location: Frankfurt, GERMANY
For investors attending the 9TH CLINICAL TRIALS INNOVATION PROGRAMME, please contact PharmAbcine Investor Relations and business development
to schedule a meeting with management at firstname.lastname@example.org.